USANA Health Sciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters

23 Apr

USANA Health Sciences Inc reports results for the quarter ended March 31 - Earnings Summary

USANA Health Sciences Inc USNA.N reported quarterly adjusted earnings of 73 cents per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 86 cents. The lone analyst forecast for the quarter was for earnings of 70 cents per share.
Revenue rose 9.5% to $249.54 million from a year ago; analysts expected $243.04 million.
USANA Health Sciences Inc's reported EPS for the quarter was 49 cents.
USANA Health Sciences Inc shares had fallen by 11.6% this quarter and lost 33.6% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 16.2% in the last three months.
In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

Wall Street's median 12-month price target for USANA Health Sciences Inc is $61.00

This summary was machine generated from LSEG data April 22 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING	ESTIMATE	ACTUAL	BEAT, MET, MISSED
Mar. 31 2025	0.70	0.73	Beat
Dec. 31 2024	0.49	0.64	Beat
Sep. 30 2024	0.49	0.56	Beat
Jun. 30 2024	0.65	0.54	Missed

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2529256899"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2529256899\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2529256899?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-23 05:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2529256899","market":"nz","top_or_hot":-1,"title":"USANA Health Sciences Inc reports results for the quarter ended March 31 - Earnings Summary","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>USANA Health Sciences Inc reports results for the quarter ended March 31 - Earnings Summary</title></head><body><ul><li><p>USANA Health Sciences Inc <span>USNA.N</span> reported quarterly adjusted earnings of 73 cents per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 86 cents.  The lone analyst forecast for the quarter was for earnings of 70 cents per share. </p></li><li><p>Revenue rose 9.5% to $249.54 million from a year ago; analysts expected $243.04 million. </p></li><li><p>USANA Health Sciences Inc's reported EPS for the quarter was 49 cents.</p></li><li><p>USANA Health Sciences Inc shares had fallen by 11.6% this quarter and lost 33.6% so far this year.</p></li></ul><p>FORECAST CHANGES</p><ul><li><p>The mean earnings estimate of analysts had fallen by about 16.2% in the last three months. </p></li><li><p>In the last 30 days, one analyst negatively revised an earnings estimate</p></li></ul><p>RECOMMENDATIONS</p><ul><li></li><li><p>Wall Street's median 12-month price target for USANA Health Sciences Inc is $61.00 </p></li></ul><p>This summary was machine generated from LSEG data April 22 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p><table><tbody><tr><td><p>QUARTER ENDING</p></td><td><p>ESTIMATE </p></td><td><p>ACTUAL</p></td><td><p>BEAT, MET, MISSED</p></td></tr><tr><td><p>Mar. 31 2025 </p></td><td><p>0.70</p></td><td><p>0.73</p></td><td><p>Beat</p></td></tr><tr><td><p>Dec. 31 2024 </p></td><td><p>0.49</p></td><td><p>0.64</p></td><td><p>Beat</p></td></tr><tr><td><p>Sep. 30 2024 </p></td><td><p>0.49</p></td><td><p>0.56</p></td><td><p>Beat</p></td></tr><tr><td><p>Jun. 30 2024 </p></td><td><p>0.65</p></td><td><p>0.54</p></td><td><p>Missed</p></td></tr></tbody></table></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>USANA Health Sciences Inc reports results for the quarter ended March 31 - Earnings Summary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUSANA Health Sciences Inc reports results for the quarter ended March 31 - Earnings Summary\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-04-23 05:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>USANA Health Sciences Inc reports results for the quarter ended March 31 - Earnings Summary</title></head><body><ul><li><p>USANA Health Sciences Inc <span>USNA.N</span> reported quarterly adjusted earnings of 73 cents per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 86 cents.  The lone analyst forecast for the quarter was for earnings of 70 cents per share. </p></li><li><p>Revenue rose 9.5% to $249.54 million from a year ago; analysts expected $243.04 million. </p></li><li><p>USANA Health Sciences Inc's reported EPS for the quarter was 49 cents.</p></li><li><p>USANA Health Sciences Inc shares had fallen by 11.6% this quarter and lost 33.6% so far this year.</p></li></ul><p>FORECAST CHANGES</p><ul><li><p>The mean earnings estimate of analysts had fallen by about 16.2% in the last three months. </p></li><li><p>In the last 30 days, one analyst negatively revised an earnings estimate</p></li></ul><p>RECOMMENDATIONS</p><ul><li></li><li><p>Wall Street's median 12-month price target for USANA Health Sciences Inc is $61.00 </p></li></ul><p>This summary was machine generated from LSEG data April 22 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p><table><tbody><tr><td><p>QUARTER ENDING</p></td><td><p>ESTIMATE </p></td><td><p>ACTUAL</p></td><td><p>BEAT, MET, MISSED</p></td></tr><tr><td><p>Mar. 31 2025 </p></td><td><p>0.70</p></td><td><p>0.73</p></td><td><p>Beat</p></td></tr><tr><td><p>Dec. 31 2024 </p></td><td><p>0.49</p></td><td><p>0.64</p></td><td><p>Beat</p></td></tr><tr><td><p>Sep. 30 2024 </p></td><td><p>0.49</p></td><td><p>0.56</p></td><td><p>Beat</p></td></tr><tr><td><p>Jun. 30 2024 </p></td><td><p>0.65</p></td><td><p>0.54</p></td><td><p>Missed</p></td></tr></tbody></table></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"USNA","symbol_name":"优莎娜","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nL8N3R02AV:1","article_id":"2529256899","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2529256899","pubTimestamp":1745355708,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"USANA Health Sciences Inc reports results for the quarter ended March 31 - Earnings SummaryUSANA Health Sciences Inc USNA.N reported quarterly adjusted earnings of 73 cents per share for the quarter e","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"USNA":"优莎娜"},"translate_title":"USANA Health Sciences Inc报告截至3月31日的季度业绩-收益摘要","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"USNA":0.9},"content_text":"USANA Health Sciences Inc reports results for the quarter ended March 31 - Earnings SummaryUSANA Health Sciences Inc USNA.N reported quarterly adjusted earnings of 73 cents per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 86 cents.  The lone analyst forecast for the quarter was for earnings of 70 cents per share. Revenue rose 9.5% to $249.54 million from a year ago; analysts expected $243.04 million. USANA Health Sciences Inc's reported EPS for the quarter was 49 cents.USANA Health Sciences Inc shares had fallen by 11.6% this quarter and lost 33.6% so far this year.FORECAST CHANGESThe mean earnings estimate of analysts had fallen by about 16.2% in the last three months. In the last 30 days, one analyst negatively revised an earnings estimateRECOMMENDATIONSWall Street's median 12-month price target for USANA Health Sciences Inc is $61.00 This summary was machine generated from LSEG data April 22 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)QUARTER ENDINGESTIMATE ACTUALBEAT, MET, MISSEDMar. 31 2025 0.700.73BeatDec. 31 2024 0.490.64BeatSep. 30 2024 0.490.56BeatJun. 30 2024 0.650.54Missed","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}